679 related articles for article (PubMed ID: 11466383)
1. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.
Abreu MT; Vora P; Faure E; Thomas LS; Arnold ET; Arditi M
J Immunol; 2001 Aug; 167(3):1609-16. PubMed ID: 11466383
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.
Cario E; Rosenberg IM; Brandwein SL; Beck PL; Reinecker HC; Podolsky DK
J Immunol; 2000 Jan; 164(2):966-72. PubMed ID: 10623846
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
Melmed G; Thomas LS; Lee N; Tesfay SY; Lukasek K; Michelsen KS; Zhou Y; Hu B; Arditi M; Abreu MT
J Immunol; 2003 Feb; 170(3):1406-15. PubMed ID: 12538701
[TBL] [Abstract][Full Text] [Related]
4. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium.
Naik S; Kelly EJ; Meijer L; Pettersson S; Sanderson IR
J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):449-53. PubMed ID: 11396812
[TBL] [Abstract][Full Text] [Related]
5. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells.
Abreu MT; Arnold ET; Thomas LS; Gonsky R; Zhou Y; Hu B; Arditi M
J Biol Chem; 2002 Jun; 277(23):20431-7. PubMed ID: 11923281
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
[TBL] [Abstract][Full Text] [Related]
7. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.
Vora P; Youdim A; Thomas LS; Fukata M; Tesfay SY; Lukasek K; Michelsen KS; Wada A; Hirayama T; Arditi M; Abreu MT
J Immunol; 2004 Nov; 173(9):5398-405. PubMed ID: 15494486
[TBL] [Abstract][Full Text] [Related]
8. MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells.
Lenoir C; Sapin C; Broquet AH; Jouniaux AM; Bardin S; Gasnereau I; Thomas G; Seksik P; Trugnan G; Masliah J; Bachelet M
Life Sci; 2008 Feb; 82(9-10):519-28. PubMed ID: 18215718
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
[TBL] [Abstract][Full Text] [Related]
10. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
Yang H; Young DW; Gusovsky F; Chow JC
J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
[TBL] [Abstract][Full Text] [Related]
11. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
[TBL] [Abstract][Full Text] [Related]
12. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
[TBL] [Abstract][Full Text] [Related]
13. TLR signaling at the intestinal epithelial interface.
Abreu MT; Thomas LS; Arnold ET; Lukasek K; Michelsen KS; Arditi M
J Endotoxin Res; 2003; 9(5):322-30. PubMed ID: 14577850
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
Bulut Y; Faure E; Thomas L; Equils O; Arditi M
J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
[TBL] [Abstract][Full Text] [Related]
15. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide.
Ohnishi T; Muroi M; Tanamoto K
J Immunol; 2001 Sep; 167(6):3354-9. PubMed ID: 11544325
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.
Akashi S; Shimazu R; Ogata H; Nagai Y; Takeda K; Kimoto M; Miyake K
J Immunol; 2000 Apr; 164(7):3471-5. PubMed ID: 10725698
[TBL] [Abstract][Full Text] [Related]
17. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling.
Fichorova RN; Cronin AO; Lien E; Anderson DJ; Ingalls RR
J Immunol; 2002 Mar; 168(5):2424-32. PubMed ID: 11859134
[TBL] [Abstract][Full Text] [Related]
18. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4.
Equils O; Faure E; Thomas L; Bulut Y; Trushin S; Arditi M
J Immunol; 2001 Feb; 166(4):2342-7. PubMed ID: 11160291
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells.
Otte JM; Cario E; Podolsky DK
Gastroenterology; 2004 Apr; 126(4):1054-70. PubMed ID: 15057745
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum.
Gomi K; Kawasaki K; Kawai Y; Shiozaki M; Nishijima M
J Immunol; 2002 Mar; 168(6):2939-43. PubMed ID: 11884465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
